|
Product Genesis Joins
CIMIT's Industry Liasion Program

Product
Genesis is pleased to announce that they have joined the CIMIT (Center for
Integration of Medicine and Innovative Technology) Industry Liaison
Program.
Product
Genesis has particular interest in emerging technologies that could support
the ambulatory practice of the future, and living laboratory projects that
involve crossover and potentially disruptive technologies. Product Genesis
is interested in providing support in many phases of investigations that
involve the application of new technologies to emerging needs in the
healthcare environment.
View the Press Release here...
|
|
|
Dear Strategic Innovator,
Welcome to the March issue of Accelerating
Success, the Newsletter for Strategic Innovators. In each issue, we
try to bring you the latest information on tools, techniques and
successes from the application of Strategic Innovation to build value and
sustainable competitive advantage in companies like yours.
|
|
|
|
|
|
|
|
|
Product Genesis Conference Paper Available...
|
|
|
On March 10, 2005 Jeff Hovis, Managing Principal at
Product Genesis, presented his paper titled, "Observations from
Technology Cross-Over Activity in the Boston and Cambridge Biotech
Community" for the Technology Convergence Track at the BioTech
2005 Conference, in Miami, Florida.
Mr.
Hovis' paper addresses significant innovation opportunities presented by
the convergence of technologies from biotechnology research, medical
devices, clinical diagnostics, micro-fluidics and information technology.
Download the PDF here...
|
|
|
|
|
|
|
Services for Technology Directors
|
|
|

Are you
challenged with maximizing the return from your company's advanced
technology investments, and struggling with how to accelerate your
company's success?
Opportunity
Genesis is applicable to challenges presented by both
pre-commercial technologies and underutilized established technologies.
The adaptable approach is successful at both tightly bounded and
unbounded opportunity explorations. The result is value created from
underutilized technology assets.
Learn more...
|
|
|
|
|
|